Pancreatic Cancer Research

ResearcherNorthwell HealthNo recent work listed

Jeffrey Chi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4730-5832; OpenAlex author ID A5091572165. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers

Papers 3

  1. The role of PARP inhibitors in BRCA mutated pancreatic cancer. Co-author DOI 10.1177/17562848211014818↗
  2. The Role of Olaparib in Metastatic Pancreatic Cancer. Co-author PMID 34151318↗
  3. Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer. First author DOI 10.1177/1756284820974912↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muhammad Wasif Saif · 3 shared papers, 2020–2021 · strength 0.47
  2. Ruwan Y. Parakrama · 1 shared paper, 2021 · strength 0.16
  3. Nausheen Hakim · 1 shared paper, 2020 · strength 0.12
  4. Shreya Prasad Goyal · 1 shared paper, 2020 · strength 0.12
  5. Hasan Rehman · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.